Clinical characteristics and outcomes of immune checkpoint inhibitor-induced diabetes mellitus

OBJECTIVE: To better understand immune checkpoint inhibitor (ICI)-induced diabetes mellitus (DM) in cancer patients. DESIGN AND METHOD: We present a case of ICI-induced diabetic ketoacidosis (DKA) and conduct a systematic review of the PubMed and Web of Science databases up to September 2021 to iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jia, Shi, Yuequan, Liu, Xiaoyan, Zhang, Dongming, Zhang, Haoran, Chen, Minjiang, Xu, Yan, Zhao, Jing, Zhong, Wei, Wang, Mengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334308/
https://www.ncbi.nlm.nih.gov/pubmed/35905639
http://dx.doi.org/10.1016/j.tranon.2022.101473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334308/
https://www.ncbi.nlm.nih.gov/pubmed/35905639
http://dx.doi.org/10.1016/j.tranon.2022.101473

Ejemplares similares